SHANGHAI PHARMACEUTICALS HOLDING financial statements, including revenue, expenses, profit, and loss

The total revenue of 601607 for the last quarter is 69.94 B CNY, and it's 11.74% higher compared to the previous quarter. The net income of Q1 24 is 1.54 B CNY.